日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Three Versus 6 Months of Adjuvant Oxaliplatin-Fluoropyrimidine Chemotherapy for Colorectal Cancer: Final Results of SCOT-An International, Randomized, Phase III, Noninferiority Trial

结直肠癌辅助奥沙利铂-氟尿嘧啶化疗3个月与6个月的比较:SCOT国际随机III期非劣效性试验的最终结果

Iveson, Timothy; Saunders, Mark P; Kelly, Caroline; Kerr, Rachel S; Cassidy, Jim; Hollander, Niels Henrik; Tabernero, Josep; Haydon, Andrew; Glimelius, Bengt; Harkin, Andrea; Allan, Karen; McQueen, John; Pearson, Sarah; Boyd, Kathleen A; Briggs, Andrew H; Waterston, Ashita; Medley, Louise; Ellis, Richard; Dhadda, Amandeep S; Harrison, Mark; Falk, Stephen; Rees, Charlotte; Olesen, Rene K; Propper, David; Bridgewater, John; Azzabi, Ashraf; Cunningham, David; Hickish, Tamas; Gollins, Simon; Wasan, Harpreet S; Church, David; Domingo, Enric

Zanidatamab in HER2-Positive Metastatic Biliary Tract Cancer: Final Results From HERIZON-BTC-01

Zanidatamab治疗HER2阳性转移性胆道癌:HERIZON-BTC-01研究的最终结果

Pant, Shubham; Fan, Jia; Oh, Do-Youn; Choi, Hye Jin; Kim, Jin Won; Chang, Heung-Moon; Bao, Lequn; Sun, Hui-Chuan; Macarulla, Teresa; Xie, Feng; Metges, Jean-Phillippe; Ying, Jie'er; Bridgewater, John; Lee, Myung-Ah; Tejani, Mohamedtaki A; Chen, Emerson Y; Wasan, Harpreet; Ducreux, Michel; Bao, Yuanyuan; Wu, Xiaotian; Zhao, Yi; Garfin, Phillip M; Gable, Jonathon; Harding, James J

Advanced ampullary cancer: post-hoc analysis of the ABC-01, ABC-02, and ABC-03 clinical trials

晚期壶腹癌:ABC-01、ABC-02 和 ABC-03 临床试验的事后分析

Lamarca, Angela; Ross, Paul; Wasan, Harpreet S; Hubner, Richard A; McNamara, Mairéad G; Lopes, Andre; Palmer, Daniel; Valle, Juan W; Bridgewater, John

Encorafenib, Cetuximab, and mFOLFOX6 in BRAF-Mutated Colorectal Cancer

恩科拉非尼、西妥昔单抗和mFOLFOX6治疗BRAF突变型结直肠癌

Elez, Elena; Yoshino, Takayuki; Shen, Lin; Lonardi, Sara; Van Cutsem, Eric; Eng, Cathy; Kim, Tae Won; Wasan, Harpreet Singh; Desai, Jayesh; Ciardiello, Fortunato; Yaeger, Rona; Maughan, Timothy S; Morris, Van K; Wu, Christina; Usari, Tiziana; Laliberte, Robert; Dychter, Samuel S; Zhang, Xiaosong; Tabernero, Josep; Kopetz, Scott

Encorafenib, cetuximab and chemotherapy in BRAF-mutant colorectal cancer: a randomized phase 3 trial

恩科拉非尼、西妥昔单抗和化疗治疗BRAF突变型结直肠癌:一项随机3期试验

Kopetz, Scott; Yoshino, Takayuki; Van Cutsem, Eric; Eng, Cathy; Kim, Tae Won; Wasan, Harpreet Singh; Desai, Jayesh; Ciardiello, Fortunato; Yaeger, Rona; Maughan, Timothy S; Beyzarov, Elena; Zhang, Xiaoxi; Ferrier, Graham; Zhang, Xiaosong; Tabernero, Josep

Pancreatic Adenocarcinoma: Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial

胰腺腺癌:ESPAC4 III期试验中辅助治疗的长期结果

Palmer, Daniel H; Jackson, Richard; Springfeld, Christoph; Ghaneh, Paula; Rawcliffe, Charlotte; Halloran, Christopher M; Faluyi, Olusola; Cunningham, David; Wadsley, Jonathan; Darby, Suzanne; Meyer, Tim; Gillmore, Roopinder; Lind, Pehr; Glimelius, Bengt; Falk, Stephen; Ma, Yuk Ting; Middleton, Gary William; Cummins, Sebastian; Ross, Paul J; Wasan, Harpreet; McDonald, Alec; Crosby, Tom; Hammel, Pascal; Borg, David; Sothi, Sharmila; Valle, Juan W; Mehrabi, Arianeb; Bailey, Peter; Tjaden, Christine; Michalski, Christoph; Hackert, Thilo; Büchler, Markus W; Neoptolemos, John P

A targeted literature review on the impact of tailored interventions on patient outcomes in oncology

针对肿瘤科个体化干预措施对患者预后影响的文献综述

Ferrier, Graham; Filipovic, Aleksandra; Wasan, Harpreet; di Pietro, Alessandra; Mittal, Deepali; Kamath, Geetanjali; Kharawala, Saifuddin; Mehmud, Faisal

Supporting cancer research on real-world data: extracting colorectal cancer status and explicitly written TNM stages from free-text imaging and histopathology reports

支持基于真实世界数据的癌症研究:从自由文本的影像和组织病理学报告中提取结直肠癌状态和明确书写的TNM分期

Tamm, Andres; Jones, Helen J S; Doshi, Neel; Perry, William; Withers, Jaimie; Salih, Hizni; Noble, Theresa; Varnai, Kinga Anna; Little, Stephanie; Roadknight, Gail; Campell, Des; Matharu, Sheila; Starling, Naureen; Teare, Marion; Galdikas, Algirdas; Glampson, Ben; Mercuri, Luca; Papadimitriou, Dimitri; Wasan, Harpreet; Scanlon, Lauren A; Malcomson, Lee; O'Hara, Catherine; Renehan, Andrew; Nicholson, Brian D; Davies, Jim; Morris, Eva J A; Woods, Kerrie; Cunningham, Chris

ABC-12: exploring the microbiome in patients with advanced biliary tract cancer in a first-line study of durvalumab (MEDI4736) in combination with cisplatin/gemcitabine

ABC-12:一项一线研究,旨在探索晚期胆道癌患者接受度伐利尤单抗(MEDI4736)联合顺铂/吉西他滨治疗后的微生物组变化。

Vrana, Eleni; Timmins, Hayley; Osborne, Ashley; Cox, Rebecca; Wasan, Harpreet; Ma, Yuk Ting; Arora, Arvind; Faluyi, Olusola; Gillmore, Roopinder; Corrie, Pippa; Miller, Paul; Arif, Seema; Canham, Joanna; Martin, Charlotte; Riaz, Muhammad; Shi, Tongtong; Frizziero, Melissa; Foy, Victoria; Hubner, Richard A; Morement, Helen; Bridgewater, John; Adams, Richard; Valle, Juan W; McNamara, Mairéad G

The potential benefit of encorafenib plus cetuximab with chemotherapy compared with standard of care in people with BRAF V600E-mutant metastatic colorectal cancer in the BREAKWATER study: a plain language summary

BREAKWATER 研究中,恩考拉非尼联合西妥昔单抗加化疗与标准治疗相比,在 BRAF V600E 突变转移性结直肠癌患者中的潜在获益:简明语言摘要

Kopetz, Scott; Yoshino, Takayuki; Van Cutsem, Eric; Eng, Cathy; Kim, Tae Won; Wasan, Harpreet Singh; Desai, Jayesh; Ciardiello, Fortunato; Yaeger, Rona; Maughan, Timothy S; Beyzarov, Elena; Zhang, Xiaoxi; Ferrier, Graham; Zhang, Xiaosong; Tabernero, Josep